Growth Metrics

Profound Medical (PROF) Cash from Operations (2018 - 2026)

Profound Medical has reported Cash from Operations over the past 8 years, most recently at 6566000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 11.69% year-over-year to 6566000.0; the TTM value through Dec 2025 reached 38207000.0, down 62.91%, while the annual FY2025 figure was 38207000.0, 62.91% down from the prior year.
  • Cash from Operations for Q4 2025 was 6566000.0 at Profound Medical, up from 9614000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 29595000.0 in Q3 2021 and troughed at 44982000.0 in Q4 2022.
  • A 5-year average of 5994350.0 and a median of 6392500.0 in 2024 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: soared 779.98% in 2021 and later crashed 225.32% in 2022.
  • Year by year, Cash from Operations stood at 39667000.0 in 2021, then dropped by 13.4% to 44982000.0 in 2022, then skyrocketed by 83.71% to 7329000.0 in 2023, then grew by 19.78% to 5879000.0 in 2024, then dropped by 11.69% to 6566000.0 in 2025.
  • Business Quant data shows Cash from Operations for PROF at 6566000.0 in Q4 2025, 9614000.0 in Q3 2025, and 13744000.0 in Q2 2025.